Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400 — Dallas, Texas

Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400 is a clinical research site located in Dallas, Texas, United States 75246.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400 has participated in 1 clinical trials.

Therapeutic areas: Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Third Line.

Sponsors: EMD Serono Research & Development Institute, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dallas

Browse all research sites in Texas · View every site in Dallas

• Medical City Spine Hospital - Southwest Scoliosis Institute
• Baylor Scott and White Heart and Vascular Hospital-Dallas
• University Texas Southwestern INT
• VA Medical Center
• Baylor Scott & White The Heart Hospital - Dallas
• MDRI Baylor University
• Baylor Research University Medical Center
• The University of Texas Southwestern Medical Center-IDS Aston Pharmacy
• The University of Texas Southwestern Medical Center in Dallas
• University of Texas Southwestern Medical Center-Parkland Hospital
• Site 19: University of Texas Southwestern
• Baylor Research Institute/Baylor Sammons Cancer Center/Baylor University Medical Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400?

Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400 conducted?

Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400 has 1 clinical trials on record. Their work covers Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Third Line.

Is Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400 accredited by Crixeo Clinical Trials?

Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology, P.A. 3410 Worth Street, Suites 300 & 400?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.